AIBiotech

Monday Q&A: Would you pay $200 to see the future?

A Richmond laboratory has developed a genetic test to tell you which sports you’re predisposed to excel in and which activities you might want to avoid. BizSense chats this week with the CEO of AIBioTech about the future of the company’s genetic test.

Stalking horse backs down

The local investment fund that had made a $4 million bid on the last remaining asset of a bankrupt local firm has pulled out.

A stalking horse emerges

A Richmond real estate investment fund wants to buy the last remaining asset of a bankrupt local biotech firm.